Taipei, May 27 -- Taiwan Patent Office has published Regeneron Pharmaceuticals patent application for Methods of Analyzing and Characterizing Messenger Ribonucleic Acid (mRNA) and Polyadenylation on MRNA. The invention was developed by Di Grandi Deanna, Fu Yue, Muthusamy Kathir, Palackal Nisha and Dayeh Daniel. The patent app..

Taipei, May 27 -- Regeneron Pharmaceuticals has submitted a patent application for Auto-injector and Related Methods of Use. This invention was developed by Halbig Daniel, Roumanidakis Alexander, Grygus Bryan, Laiacona Danielle, Kuchibhatla Sindhuja, Burke John and O'connell-govan Daniel. The patent application number is TW2024..

Taipei, May 27 -- Regeneron Pharmaceuticals has applied Taiwan patent for Medical Device Packaging and Related Methods. Grygus Bryan developed it. The patent application number is TW20240122174 20240614. The patent publication number is TW202515628 (A). International Patent Classification codes are A61M5/00 and A61M5/20. Cooper..

Canberra, May 26 -- Regeneron Pharmaceuticals has submitted a patent application for Systems and Methods for Correcting for Noise and Systemic Variations in Sequencing Data. This invention was developed by Chen Lei, Paulding Charles, Damask Amy, Kang Hyun Min and Hawes Alicia. The patent application number is AU20240211119 2024..

Geneva, May 26 -- World Intellectual Property Organization has released Regeneron Pharmaceuticals patent application for Systems and Methods for Drug Delivery to Ocular Tissue. This invention was developed by Grygus Bryan C, Langley Trevor, Zarev Angel, Mckay Fraser, Barty Matthew and Peachey Ted. The patent application number ..

Buenos Aires, May 26 -- Regeneron Pharmaceuticals has applied Argentine patent for Anticuerpo Anti Glicoproteína Espiga De Sars.cov.2 Y Fragmentos De Unión a Antígeno. Baum Alina, Kyratsous Christos and Yancopoulos George D developed it. The patent application number is AR2022P101852 20220714. The patent publication number..

Beijing, May 25 -- State Intellectual Property Office of China has released Regeneron Pharmaceuticals patent application for Methods and Compositions for Increasing Homologous Directed Repair. This invention was developed by Li Weiting and Bonetti Ciro. The patent application number is CN20248043139 20240628. The patent publica..

Alexandria, May 25 -- Regeneron Pharmaceuticals has filed a patent application for Anti-SLC3A2-APIS Antigen-binding Proteins and Methods of Use Thereof. This invention was developed by Van Meter Michael and Kuhnert Frank. The patent application number is US202519310327 20250826. The patent publication number is US20260139069 ..